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Antibiotics have been intensively used over the last decades in human and animal therapy and livestock, resulting in serious
environmental and public health problems, namely due to the antibiotic residues concentration in wastewaters and to the
development of antibiotic-resistant bacteria. This study aimed to access the contribution of some anthropological activities, namely
urban household, hospital and a wastewater treatment plant, to the spread of antibiotic resistances in the treated wastewater released
into the Mondego River, Coimbra, Portugal. Six sampling sites were selected in the wastewater network and in the river. The
ampicillin-resistant Enterobacteriaceae of the water samples were enumerated, isolated and phenotypically characterized in relation
to their resistance profile to 13 antibiotics. Some isolates were identified into species level and investigated for the presence of class A
and class C b-lactamases. Results revealed high frequency of resistance to the b-lactam group, cefoxitin (53.5%), amoxicillin/
clavulanic acid combination (43.5%), cefotaxime (22.7%), aztreonam (21.3) cefpirome (19.2%), ceftazidime (16.2%) and to the non-
b-lactam group, trimethoprim/sulfamethoxazol (21.1%), tetracycline (18.2%), followed by ciprofloxacin (14.1%). The hospital
effluent showed the higher rates of resistance to all antibiotic, except two (chloramphenicol and gentamicin). Similarly, higher
resistance rates were detected in the wastewater treatment plant (WWTP) effluent compared with the untreated affluent. Regarding
the multidrug resistance, the highest incidence was recorded in the hospital sewage and the lowest in the urban waste. The majority
of the isolates altogether are potentially extended-spectrum b-lactamases positive (ESBLC) (51.9%), followed by AmpCC (44.4%)
and ESBLC/AmpCC (35.2%). The most prevalent genes among the potential ESBL producers were blaOXA (33.3%), blaTEM (24.1%)
and blaCTX-M (5.6%) and among the AmpC producers were blaEBC (38.9%), blaFOX (1.9%) and blaCIT (1.9%). In conclusion, the
hospital and the WWTP activities revealed to have the highest contribution to the spread of multidrug resistant bacteria in the study
area. Such data is important for future management of the environmental and public health risk of these contaminants. This is the
first embracing study in the water network of Coimbra region on the dissemination of antibiotic resistance determinants. Moreover,
it is also the first report with the simultaneous detection of multiresistant bacteria producers of AmpC and ESBLs b-lactamases in
aquatic systems in Portugal.
Keywords: AmpC, antibiotic-resistant bacteria, antibiotic-resistant genes, Enterobacteriaceae, environmental contaminants, ESBL,
hospital wastewater, multidrug resistance, public health, WWTP.
Introduction
The antibiotic (AB) era with about 70 years is considered
as a relatively recent event in evolutionary terms. It is
characterized by an exponential increase of antimicrobial-
resistant bacteria as a result of a large-scale AB use. Up to
date, the drugs with most successful application belong to
the AB group, used in the treatment and prevention of
bacterial infections of humans, animals and plants. Addi-
tionally, despite the use of AB as growth promoters in
intensive livestock farming is not allowed in Europe, these
can still be used as feed additives in the aquaculture indus-
try and in the poultry production.[1–3]
Antibiotics are daily excreted into the environment
through urine and feces, as a mixture of unchanged xeno-
biotic compounds and bioactive forms partially
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metabolized by humans and animals. This release,
together with antibiotic-resistant bacteria (ARB), can
occur by several routes, the major of which are the net-
work of municipal sewers and the soil farm fertilization
with manure or sewage sludge. Besides the chemical pollu-
tion by AB themselves, their long-term permanence in
most water systems, pressures selection at sub-inhibitory
concentrations upon microorganisms, resulting in the
development of ARB and antibiotic resistance genes
(ARG).[1,3–5] Consequently, the wastewater from multiple
human activities, which contains high levels of organic
and inorganic matter and also high concentrations of
microorganisms, including pathogenic, commensal and
environmental bacteria convert the sewage into an ecologi-
cal niche especially adapted to the growth and spread of
antibiotic resistances.[6]
The wastewater treatment plant (WWTP) is therefore
the meeting point of most of these resistance determinants,
particularly in those with activated sludge or percolator
biological filters for the biological treatment, acting as an
important reservoir of Enterobacteriaceae carrying resis-
tance genes potentially transferable. At these locations,
where bacterial density is high, there is a selective pressure
for resistance and increased availability of nutrients;
accordingly, the optimal conditions are gathered for the
horizontal ARG transfer between the newly arrived bacte-
rial population and the resident, thus favoring the increase
of bacterial resistance.[7-11] Some recent studies on the
evaluation of the role played by the biological WWTP on
the levels of resistance determinants showed higher percen-
tages of multiresistant bacteria in the effluent than in the
affluent of treated wastewater.[5,7–10]
The extended-spectrum b-lactamases (ESBL) are
enzymes that hydrolyze the AB of the b-lactams class,
such as penicillins, cephalosporins of the first, second and
third generation and aztreonam. Among the AB group,
this class is the most representative for human consump-
tion in most of the countries.[5,8] Nowadays, the increasing
prevalence of bacteria carrying ESBLs represent a world-
wide major clinical problem, which may cause a variety of
infections and increase the risk of therapy failure.[12–14]
Although many species of Gram negative bacteria could
host ESBLs, they are mainly Enterobacteriaceae.[14] More
than 200 different genes encoding for ESBLs are identified,
and the TEM and SHV families were the most prevalent
worldwide until the mid-1990s. Over the last 15 years,
these groups have been replaced by the CTX-M genes fam-
ily. There are however other b-lactamases that have ESBL
phenotypes, such as some members of the OXA fam-
ily.[12,15,16] The recent emergence of Gram-negative bacte-
ria harboring other type of b-lactamases known AmpC
mediated by plasmids raises new problems.
Originally these enzymes were described as chromo-
somal and inducible in Enterobacteriaceae, however cur-
rently plasmidic genes are described in seven families:
blaACC, blaCMI, blaDHA, blaFOX, blaACT, blaMOX and
blaEBC.
[17] The distinction between AmpC and ESBLs lies
on the capacity of AmpC, unlike ESBL, to hydrolyze
cefoxitin and cefotetan and not letting themselves to be
inhibited by b-lactamases inhibitors. The AmpC plasmidic
genes, which generally co-inhabit mobile genetic elements
together with ESBL and other resistance genes from other
classes of AB, are horizontally transferred to sensitive
receptor bacteria. Infections caused by co-producing
ESBL/AmpC bacteria are increasing all over the world.[18]
Consequently, all the multidrug resistance phenotypes
impose further limitations on the therapeutic options cur-
rently representing a major public health issue.[14,19–23]
The environmental problem here exposed is exacerbated
on one hand by the increasing need of food production to
meet the world population growth and on the other hand
by water scarcity for agriculture. Therefore, the treated
wastewater irrigation has benefits for all countries, but
mainly in arid and semiarid regions.[24] The wastewater
treatment, aiming the removal of those contaminants from
the effluent and consequently the mitigation of potential
negative impacts on water resources, is therefore a crucial
point for environmental management. The choice of the
type of treatment to be used will depend on the nature of
the wastewater and their final use. However, although
there has been improvements in wastewater treatment
technologies, there are many problems that still remain to
be solved, particularly safety issues.[3,5,25,26] The search for
local solutions to avoid the environmental dissemination
of these pollutants requires the knowledge of the specific
residues and the resistant determinants present in that
wastewater.
The general objective of this study is the assessment of
the pattern of AB resistance contribution of some anthro-
pological activities: household, hospital and Wastewater
Treatment Plant (WWTP) to the treated wastewater qual-
ity released into the Mondego River in the Coimbra met-
ropolitan area, Portugal.
Materials and methods
Study area
The Choupal WWTP (4013’29”N and 827’3”W) in
Coimbra is the largest WWTP exclusively with a conven-
tional treatment system by trickling filter in Portugal. It is
responsible for the sewage treatment of the University
Hospital of Coimbra (HUC), of various domestic urban
areas and some industrial wastewater effluents, represent-
ing about 220,000 inhabitants-equivalents. This infrastruc-
ture performs a biological treatment and it is dimensioned
to treat an average daily flow rate of about 40,000 m3, in a
sequence of organs comprising three phases of treatment.
The liquid phase includes the following organs: prelimi-
nary wastewater treatment (three rows of thick and thin
disking, two lines of grit removal and degreasing, two
primary clarifiers, four trickling filters and two secondary
clarifiers. The solid phase is composed by a gravitic thick-
ener, two heated anaerobic digesters, a centrifugal, seven
drying beds and a sludge park. The gas phase (biogas pro-
duction), has two mobile summit gasometers, a heating
sludge system and a turbine powered by biogas for electric-
ity production. The treated effluent is daily unloaded into
the Lower Mondego River that runs for about 40 kilo-
meters, an extremely fertile alluvial plain with the most
productive rice fields of Europe.[27,28]
Sample collection
The six sampling sites selected for this study (Fig. 1) include
the affluent (AWWTP) and effluent (EWWTP) of the Cou-
pal WWTP; the wastewater collector boxes of the city urban
area (CWW) and the hospital (HWW); and the surface water
of the Mondego River, upstream (URW) and downstream
(DRW) the WWTP treated effluent discharge. Sampling
was carried out between April and July, in three different
periods. All samples were collected in 1L sterile plastic bot-
tles andmaintained at 4C until the microbiological process-
ing, which was always carried out within 4 h after sampling.
Water river samples were collected at a depth of 0.5 m and a
distance of 2 m from the river bank.
Physicochemical parameters
The physicochemical parameters of river and wastewater
samples included the temperature (C), determined by
thermometry; pH, determined by potentiometry; water
turbidity, measured in nephelometric turbidity units
(NTU); Water Flow (m3/h); Total Suspended Solids
(TSS), measured by Gravimetry; Biochemical Oxygen
Demand (BOD) (mg/L) determined by a manometric
method and the Chemical Oxygen Demand (COD5),
determined by potentiometric titration and expressed as
the dissolved O2 before and after 5-day incubation at 20C
in the dark (mg/L). These analyses were carried out in the
laboratory of Aguas do Mondego.
Enumeration, detection and identification of bacteria
The microbiological analysis of the water samples began
with the determination of its microbial load. In order to
obtain the number of colonies per filtration recommended
for counting (20-80), decimal dilutions were prepared in
sterile saline 0.9% NaCl. Then 100 mL of each dilution
were filtered through cellulose membranes of 0.45 mm in
pore size (Millipore, Bedford, MA, USA) under a vacuum
system and the filters aseptically placed on the surface of
selective medium for Enterobacteriaceae VRBG (Violet
Red Bile Glucose) agar (Oxoid, Hampshire, England) sup-
plemented with 20 mg/mL ampicillin (AppliChem, Darm-
stadt, Germany). After aerobic incubation of the plates for
24 h at 37C, all the Enterobacteriaceae isolates resistant
to ampicillin (AMPr) were counted. The colonies with dif-
ferent morphological types were selected, pricked out three
times and its purity microscopically confirmed. The species
identification of some isolates was performed by biochemi-
cal tests using the standard API 20E galleries (BioMerieux,
Marcy-l'Etoile, Lyon, France) according to the manufac-
turer recommendations.
Antimicrobial susceptibility testing
The isolates were tested for the antimicrobial susceptibility
using the disk diffusion Kirby-Bauer method on Mueller-
Fig. 1. Location of sampling sites in: (A) the Portugal map (approximate scale 1:11,000,000) and (B) the urban area of Coimbra city
(approximate scale 1:170,000). 1- City Wastewater (CWW); 2- Hospital Wastewater (HWW); 3- Affluent of the WWTP (AWWTP);
4- Effluent of the WWTP (EWWTP); 5- Mondego River, 500m upstream the WWTP discharge (URW); 6- Mondego River, 500 m
downstream the WWTP discharge (DRW).
Hinton agar (Oxoid, Hampshire, England) with AB disks
(Oxoid, Hampshire, England), in agreement to the Clinical
Laboratory Standards Institute tests.[29] According to the
main AB classes used in Portugal in particular, b-lactams,
quinolones, chloramphenicol, sulphonamides, tetracy-
clines, aminoglycosides, carbapenems, the following ABs
were selected: amoxicillin/clavulanic acid combination
(AMC) 30 mg/10 mg, respectively; ceftazidime (CAZ)
30 mg; cefotaxime (CTX) 30 mg; cefpirome (CPO) 30 mg;
aztreonam (ATM) 30 mg; cefoxitin (FOX) 30 mg; imipe-
nem (IPM) 10 mg; meropenem (MEM) 10 mg; chloram-
phenicol (CHL) 30 mg; tetracycline (TET) 30 mg;
gentamicin (GEN) 10 mg; trimethoprim/sulfamethoxazol
(SXT) combination (1:19) and ciprofloxacin (CIP) 5 mg.
The isolate Escherichia coli ATCC25922 (Liofilchem S.R.
L., Roseto degli Abruzzi, Italy), E. coli J53 (AzR) and E.
coliHB101 (StpR) were used as quality controls in the min-
imal inhibitory concentration (MICs) assays.
Determination of MAR index
The Multiple Antibiotic Resistance (MAR) index per sam-
pling sites was calculated according to Krumperman[30] to
compare the contribution of each human activity upon the
environmental and public health risk. This calculation
considered 13 of the tested AB, as ampicillin was excluded
since the medium to select the isolates was AMP supple-
mented. The sites with an index equal or below 0.2 are
considered at low risk of contamination, where AB
are rarely or never used, while sites with index above 0.2
are considered at high risk of contamination, due to the
constant and high AB exposure.
Detection of ESBL and AmpC genes
The presence of the most frequent Enterobacteriaceae bla
genes in the isolates under study was determined by differ-
ent multiplex PCR. These included the blaTEM, blaSHV,
blaOXA and blaCTX-M gene group encoding various ESBLs
and the variants of blaACC, blaFOX, blaMOX, blaDHA, bla-
CIT and blaEBC genes coding for the family of b-lactamase
AmpC. Some isolates were selected, according to their
phenotypic resistance profile, for total DNA extraction
and used as a template in the PCR amplifications. PCR
reactions were performed in a thermocycler (iCycler, Bio-
rad, Thermal Cycler, Hercules, CA, USA) with primers
and under conditions described by Dallenne et al.[17] All
PCR reactions were performed in 25 mL volume contain-
ing DNA (1 mL), 1x PCR buffer (200 mM Tris-HCl, pH
8.4, 500 mM KCl), deoxynucleoside triphosfate
(200 mM), MgCl2 (1.5 mM), Taq DNA polymerase
(0.5U, Invitrogen) and a variable concentration of group
specific primers (0.4 pmol/mL for ESBL PCR and 0.2
pmol/mL for AmpC PCR). The cycling conditions
included 10 min of denaturation at 94C; 30 cycles of
94C for 40s, 60C for 40s and 72C for 1min; followed by
a final extension at 72C for 7 min. Strains used as positive
controls in PCR amplifications were: E. coli HY0401091
(for blaCTX-M-2), E. coli UB0402407 (for blaCTX-M-9 and
blaTEM), K. pneumoniae HY0301692 (for blaCTX-M-1, bla-
TEM and blaSHV), K. pneumoniae AA0404346 and K. pneu-
moniae MR0500681 (for blaSHV). Negative controls
without DNA were always included. The amplification
products were separated by electrophoresis on a 1% aga-
rose gel (BioRad) stained with ethidium bromide (125 mg/
mL) and visualized under a UV transillumination (Vilber
Lourmat, France).
Results and discussion
Physicochemical and microbiological parameters
The physicochemical parameters of the river and wastewa-
ter samples are shown in Table 1. The average tempera-
ture observed in the samples ranged between 16–17C.
Based on these data, the physicochemical parameters of
the river water quality was described as satisfactory and is
consistent with the results advised by Marecos do Monte
and Albuquerque.[31]
The quantification of the AmpR Enterobacteriaceae in
wastewater samples collected at the WWTP entrance and
departure, showed a decrease to about half (7.7%, 2.0 £
106 cfu/mL) (Table 1). These results are in agreement
with those reported by Marecos do Monte and Albuquer-
que[31]: a decrease of total coliforms in untreated water of
107 to 109 and a reduction in treated water of 10 to 100.
Similar results had been found by Korzeniewska et al.[5]:
a 2 log reduction of the mean values of E. coli. In this
study, the highest values were recorded in the urban and
hospital wastewaters, 3.6 £ 106 § 1.64 cfu mL¡1 and
5.8 £ 106 § 0.53 cfu mL¡1, which is not surprising since
these are highly populated areas. In contrast, in the river
samples there were a 44.5-times increase (9375%, 4.5 £
104 cfu mL¡1) between samples collected upstream and
downstream WWTP effluent discharging point. Similar
results were obtained by Li et al.,[32] who found a 1 log
increase of the total number of cells between river sam-
pling sites upstream and downstream of the WWTP dis-
charge point.
Antibiotic resistance profile
A total of 383 AmpR isolates of the Enterobacteriaceae
family were obtained from the six sampling sites: 72
(AWWTP), 67 (EWWTP), 84 (CWW), 81 (HWW), 40
(URW) and 39 (DRW). A comprehensive analysis of
results reveals that these isolates have a particularly high
frequency of resistance to the b-lactam group, FOX
(53.5%), AMC (43.5%), CTX (22.7%), ATM (21.3) CPO
(19.2%), CAZ (16.2%) and to the non-b-lactam group,
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SXT (21.1%), TET (18.2%), followed by CIP (14.1%)
(data not shown). The high b-lactams resistance might be
explained by its intensive use in Portugal, as according to
the INFARMED[33] report, the b-lactams were still the
AB group mostly sold, reaching total of 33.3% of all AB
packages sold in the country.
Within the non-b-lactam group, fluoroquinolone (CIP)
and sulfonamide (SXT) had a significant number of sales.
The former, was the AB with the highest consumption
increase over the last decade, being Portugal the 6th-largest
consumer of fluoroquinolones in Europe, and currently
accounting for about 9% of the total ambulatory AB con-
sumption.[33-35] In addition, the intensive use of TET in
veterinary practice justifies the high spread of resistance to
this AB in water resources.[36,37]
Comparing the AB resistance profiles from the different
sampling sites, the hospital effluent showed the higher rates
of resistance to all AB, having only two (CHL and GEN) a
resistance rate lower than 15% (Fig. 2A). Similarly, Korze-
niewska et al.[5] reported higher rate of AB-resistant E. coli
in the wastewater of hospital effluent in relation to the
urban area. As expected, these data indicate that the clinical
activity is a major route of environmental spread of AB-
resistant Enterobacteriaceae, once large doses of such drugs
are daily used on patients, thereby increasing the selective
pressure and thus the emergence of resistant bacteria.
Fig. 2. Antibiotic resistance of Enterobacteriaceae isolates obtained from six sampling sites A) Relative frequency of resistance pat-
terns exhibited by resistant and intermediate resistant isolates to 14 AB (13 tested C 1 used for bacteria screening); B) Relative fre-
quency of isolates exhibiting multiple AB resistance. Tested AB: nine b-lactams: ampicillin (AMP), amoxicillin/clavulanic acid
(AMC), ceftazidime (CAZ), cefotaxime (CTX), cefpirome (CPO), aztreonam (ATM), cefoxitin (FOX), imipenem (IPM), meropenem
(MEM) and non-b-lactams: chloramphenicol (CHL), tetracycline (TET), gentamicin (GEN), trimethoprim/ sulfamethoxazol
(SXT) and ciprofloxacin (CIP). Sampling sites: AWWTP, Affluent of the WWTP; EWWTP, Effluent of the WWTP; CWW, City
Wastewater; HWW, Hospitals Wastewater; URW, Mondego River 500 m upstream the WWTP discharge; DRW, Mondego River
500 m downstream the WWTP discharge.
The isolates from the urban domestic wastewater exhib-
ited the highest resistance rates to AMC (23.8%), FOX
(32.1%) and TET (13.1%); however, no resistance was
detected to MEM and IPM (Fig. 2A). The highest resis-
tance to these two AB (17.3% and 21.0%, respectively) was
registered in the isolates from hospital effluents. This result
can be explained, once both AB of the carbapenems class,
are mainly used in hospitals as a last resort, often in com-
bination with other AB to treat patients in hospital with
severe infections.[38]
Curiously, the isolates from the WWTP effluent have
higher rates of resistance to all tested AB, with emphasis
on FOX (55.2%), AMC (49.3%), CTX (23.9%), ATM
(23.9%), TET (26.9%) and SXT (32.8%), when com-
pared with those obtained from the WWTP entrance
sampling site. The higher resistance values at this site
were to AMC (43.1%) and FOX (44.4%) (Fig. 2A). Sim-
ilar results were reported by Li et al.[32] in a WWTP
receiving a pharmaceutical industry effluent, which pro-
duce penicillin G. These authors found significantly
higher levels of resistance to almost all tested AB in the
isolates obtained downstream the WWTP compared to
those collected upstream the plant; and pointed as a
putative explanation for these results, the biological
treatment plant system used as the secondary treatment,
the trickling bed filter. In fact, it appears that this
WWTP ecosystem is an important reservoir of bacteria
containing ARG that potentially can be horizontally
transferred to the newcomer bacteria, thus favoring the
increase of bacterial resistance.[8,9-11]
Additionally, the river isolates sampled after the
WWTP discharge point, have higher AB resistance (with
highlight for AMC, 53.8%; FOX, 51.3% and SXT,
25.6%) when compared to those sampled upstream the
WWTP, exception for CTX (10.3%), CHL (5.1%) and
GEN (5.1%) (Fig. 2A). These results reinforce the
importance of appropriate treatments in the WWTP
aiming reducing the spread to the environment of resis-
tance determinants, namely ARB and ARG. However,
it should be noted that the presence of ARB in the water
river sampled upstream the WWPT discharge point, is
not surprising, as some previous studies have pointed
that even in nonpolluted environments there may be
some AB resistance.[32,39]
Higher AB resistance was detected in the WWTP efflu-
ent samples compared with those sampled in the river
downstream the plant, except for AMC. Depending on
the AB, the reduction rate of resistant isolates ranges
from 7.1% (FOX) to 82.0% (MEM). This might be due
to the dilution factor, quite high in the river water. How-
ever, the resistance profile of the two sites, mainly for the
CIP, GEN, CHL, SXT and TET, is quite proportional,
which may indicate that the discharge of this treated
wastewater can contribute to the spread of these resistant
bacteria in aquatic environment, as already reported in
Poland by Koczura et al.[40] in 2012.
Regarding the multidrug resistance among the 383 iso-
lates, 66.6% were resistant to more than one of the 13 AB
tested, 55.3% of which are resistant to at least three AB.
The occurrence rate of resistant isolates to least three AB,
per sampling site is: HWW (86.9%), DRW (59.0%),
EWWTP (58.2%), URW (50.0%), AWWTP (48.6%) and
CWW (31.0%). The sampling site with the highest number
of AB resistant isolates was the hospital sewage and with
the lowest was the urban waste (Fig. 2B).
There was an increase of multiresistant isolates between
the WWTP entrance and departure, which is in agreement
with the results of other studies in WWTP, that identified
mobile genetic elements in bacteria isolated either from
the wastewater or from the biological treatment, demon-
strating that even with the reduction of the microbial load
in treated wastewater, there is a proportional increase in
multidrug-resistant bacteria.[5,8-10]
Moreover, there was an increased incidence of multi-
drug-resistant isolates between the water river sampled
before and after the treatment plant discharge point. As
mentioned above, the proportion of multiresistant isolates
is very similar among the WWTP effluent and the down-
stream river samples. These results agree with those
obtained by Koczura et al.,[40] who isolated bacteria resis-
tant to an average of seven different AB, both in the
treated WWTP effluent and in the river downstream the
WWTP discharge.
Concurrently, the multiple antibiotic resistance (MAR)
indices were determined according to Krumperman[30]
(Table 2). The MAR Index provides a method that
assesses the risk of contamination in aquatic
environments.
The MAR indices of the hospital effluent (0.42) and
the WWTP effluent (0.27) are higher than the threshold
index of 0.2, indicating their high risk of environmental
contamination and consequently rising serious problems
of water quality and public health. The index of the
river after the WWTP discharge (0.22) may indicate that
this aquifer resource is not the most adequate for the
rice fields irrigation, located downstream of the treat-
ment plant.
Table 2. Multiple Antibiotic Resistance (MAR) index of waste-
waters and river water.
Sampling sites n. isolates n. AB MAR index
Wastewaters AWWTP 72 207 0.21
EWWTP 67 252 0.27
CWW 84 184 0.16
HWW 81 479 0.42
River Water URW 40 113 0.20
DRW 39 119 0.22
Sampling sites, for codes, cf. legend of Fig. 1; n. isolates, number of
isolates; n. AB, sum of the number of antibiotic resistances per isolate.
Screening of ESBL e AmpC genes
For the screening of the most frequent bla genes of class A
or class C among Enterobacteriaceae, 54 isolates were
selected, through the susceptibility profiles, according to
their b-lactams resistance. Enterobacter cloacae was the
most prevalent species (51.3%), followed by Klebsiella
pneumoniae (12.8%), Raoultella planticola (10.3%), Serra-
tia liquefaciens (7.7%). Only two isolates were identified as
Escherichia coli (5.1%), which was therefore not the most
representative species in this study, conversely to what is
reported by many authors (Table 3).
The majority of the isolates are potentially ESBLC
(51.9%), 44.4% are AmpCC and 35.2% are ESBLC/
AmpCC. The most representative species, Enterobacter
cloacae, belongs to the latter genotype. However, Entero-
bacter sakazaki was the species that harbored the majority
of the bla genes (TEM, OXA, CTX-M-1, EBC). This per-
centage of isolates co-producers of b-lactamases AmpC
and ESBL, supports the idea that this type of microorgan-
isms, especially Enterobacteriaceae, are becoming increas-
ingly common.[41,42] In addition, as 33.3% of the tested
isolates were negative for all genes detected, it suggests
that the enzymes involved in the phenotypic resistance are
different from those searched in this study, being therefore
necessary to search for other less common genes, including
blaEBV, blaPER, blaGES, blaIMP, blaVIM and blaKPC.
The most prevalent genes among the potential ESBL
producer isolates were blaOXA (33.3%) and blaTEM
(24.1%) (Table 4). No blaSHV gene was detected, and only
three isolates (5.6%) harbored the blaCTX-M gene: two of
the CTX-M-1 group and one of the CTX-M-9. The result
that these frequencies differ from other reports suggested
the prevalence of the blaCTX-M gene, in particular of the
blaCTX-M-15, which encodes for one of the most widespread
ESBL, in isolates obtained from hospitals,[22,43] agro-eco-
systems[44,45] or sewerage water.[5,42]
However, our results are partly in agreement with those
obtained by Diallo et al.,[13] who reported among the
ESBL-producing E. coli, isolated from urban wastewater,
the blaCTX-M-14 gene (11.1%), the blaTEM-52 gene (66.6%)
and from the slaughterhouse and WWTP effluents the
blaCTX-M-1 (22.2%). All those isolates also contained bla-
TEM-1 and none contained blaSHV.
The blaOXA gene was recorded in 33.3% of the ESBL-
producer isolates. This result is consistent with that
obtained by Sana et al.[46] in a study conducted in Leba-
non, showing a high prevalence of the blaOXA gene
(45.2%) among the 73 ESBL-producer clinical isolates of
E. coli analyzed.
Other studies about the AB resistance of clinical isolates
obtained from Portuguese hospitals, including the Coim-
bra hospital under study, revealed the spread of Enterobac-
teriaceae containing a combination of blaCTX-M-15-1,
blaOXA-1 and blaTEM-1 genes with others, coding for ami-
noglycosides and fluoroquinolones resistance.[47,48] The
former authors also revealed results similar to our findings,
but instead of blaOXA-1 they detected blaOXA-30, all belong-
ing to the same blaOXA-1-like group. Moreover, it appears
that all OXA isolates (except three) are resistant to at least
one carbapenem, suggesting the presence of b-lactamase
OXA carbapenemase (Table 3). Identical results were
recently reported from 21 Spanish WWTP, with preva-
lence of blaCTX-M, high frequency (47%) of blaTEM and
lower frequency (8.3%) of blaOXA genes in their
effluents.[42]
It is noteworthy that both isolates harboring blaCTX-1
group, to which blaCTXM-15 gene belongs, exhibit cipro-
floxacin resistance (Table 3). This result is consistent with
other reports, which had revealed an association between
fluoroquinolone resistance and the presence of blaCTXM-15
gene.[42,49,50]
The AB resistance profile of the isolates reveals their
clear multiresistance (Table 3). Nevertheless, sequencing
will be required to confirm whether all putative ESBL phe-
notypes are really ESBL genotypes, although ESBLs are
often associated with the multidrug resistance.[12,19] Tac~ao
et al.[51] also observed ESBL strains isolated from Portu-
guese rivers with high levels of non-b-lactam resistance,
such as tetracycline, aminoglycosides and fluoroquino-
lones. Once 59.3% of the studied isolates were resistant to
at least one carbapenem, it would also be interesting to
search for the presence of blaIMP, blaKPC and blaVIM genes,
responsible for resistance to carbapenems.
The co-production of plasmid-encoded bla genes has
been reported in Enterobacteriaceae, mainly related to the
ESBL and carbapenemases.[52] Moreover, the association
of the AmpC gene with the acquisition of additional resis-
tance genes for non-b-lactam AB has been well docu-
mented;[53,54] although, the lower frequency of studies
about the occurrence of plasmid-mediated ESBL and
AmpC co-producer isolates.[55]
The majority of the isolates carrying AmpC b-lacta-
mases, encoded by plasmid genes (94.4%) were resistant to
both cefoxitin and amoxicillin associated with clavulanic
acid (Table 3). This association has been interpreted as
simple indicative of AmpC producers. In fact, no AmpC
genes were detected in the three isolates sensitive to those
b-lactams, which for those with a FOX-resistant pheno-
type might be explained by an overexpression of the chro-
mosomal AmpC.[44]
The most prevalent genes of this b-lactamase type
belong to the blaEBC gene family (38.9%) (includes blaACT
and blaMIR-1), followed by the gene families blaFOX
(includes blaFOX-1 to blaFOX-5), blaDHA (includes blaDHA-1
and blaDHA -2) and blaCIT (includes blaCMY-2 to blaCMY-7,
blaCMY-12 to blaCMY-18, blaCMY-21 to blaCMY-23, blaLAT-1
to blaLAT-3 and blaBIL-1) with only one isolate each (1.9%).
These results do not confirm the numerous references
that indicate blaCMY-2 as the most prevalent gene in
Enterobacteriaceae encoding for the AmpC enzymes plas-
mid-mediated and its widely worldwide occurrence in
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human clinical isolates[20,53,56–58] in healthy or diseased
animals[44,59,60] and in environmental waters.[54]
In some geographical regions, the AmpC b-lactamases
especially those encoded by the blaCMY-2 gene, have become
more prevalent than the ESBL,[61] despite in other regions
the blaDHA and blaFOX are also highly prevalent.
[57] For
example, in Chinese pediatric hospitals the E. coli isolates
revealed blaDHA-1 as the most prevalent b-lactamase
(93.2%), compared to blaCMY-2, with 6.8%.
[62] Also in Indian
hospitals, Mohamudha et al.[63] reported blaDHA as the pre-
dominant (38.1%) among the AmpCproducing isolates.
The results published by Al-karawyi et al.[64] are similar
those obtained in our study. These authors analyzing iso-
lates collected from hospital urine samples of Iraqi patients
with urinary tract infections found a distribution frequency
of the AmpC of: 50% blaEBC, 44.4% blaFOX, 38.9% blaCIT
and 27.8% blaDHA. Additionally, in the USA the b-
lactamase ACT-1 (EBC family) and FOX-5 were reported
in the majority of clinical isolates, and interestingly a
minority of CMY-2 and DHA-1 producers.[65] Moreover,
with exception to the predominance of CMY-2, Galan-
Sanchez et al.[58] also observed, among the clinical isolates
of a Spanish hospital, a AmpC susceptibility pattern of
78.2% : blaTEM (51.9%), blaSHV (6.3%), blaOXA (3.8%) and
blaCTX-M (3.8%).
In our study, no genes of the blaACC and blaMOX families
were detected (Table 4); conversely toHussain et al.,[22] who
detected CIT and MOX family genes, as the most prevalent
in the clinical isolates. Moreover, none of the isolates har-
bored more than one family of AmpC, although such occur-
rence has already been registered in India by Shahid et al.[66]
Synthetizing, the higher diversity of AB resistance pheno-
types observed in the sampling sites HWW, AWWTP and
EWWTP is in agreement with the higher diversity of genes
coding forb-lactamases (Tables 3 and 4).
Conclusion
To our knowledge, this is the first study on the dissemina-
tion of AB resistance determinants in urban and hospital
wastewaters, in the receptor WWTP and their distribution
in water resources in Coimbra. Moreover, this paper
reports the simultaneous detection of multiresistant bacte-
ria producers of AmpC and ESBLs b-lactamases in
aquatic systems in Portugal.
This study has demonstrated that the high spread ofmulti-
drug-resistant bacteria detected is a consequence of the
anthropogenic activities, particularly in urban and clinical
environments. Moreover, the wastewater treatment can fur-
ther contribute to a frequency increase of these bacteria in
aquatic ecosystems; since the treatment plant is an important
reservoir ofEnterobacteriaceae containing transferable resis-
tance genes. This environmental spread of AB resistance
determinants becomes a concerning matter when the treated
wastewater is reused for crop irrigation, as in the Lower
Mondego region, where rice and other food crops are grown.
It would be important to improve combined treatments for
disinfection, investing in the development of cheapest and
easy to apply to inactivate and prevent the spread of
unwanted biological contaminants.
Given this situation, there is an urgent need for efficient
management of hospital wastewaters, since they are a
major source of environmental contamination. In
Portugal, the legislation does not impose limits to AB resi-
dues or to ARB in hospital wastewaters. Consequently, in
the absence of specific legislation, there is no accurate
information regarding those effluents, which is the
required basis to plan and implement an adequate and spe-
cific treatment of these wastewaters.
In many countries, including Portugal, there are regula-
tions regarding the use of treated wastewater in agricul-
ture. However, this regulation only sets quality
requirements upon some chemical characteristics and
thresholds to the presence of pathogenic microorganisms,
including the indicator microorganisms that may cause
risk to public health. Currently, it would be important that
legislator entities include in the regulations additional cri-
teria for wastewater quality regarding to the supervision
and control of AB multidrug-resistant bacteria.
If all these measures, including the rationalization of AB
use, the investment in the production of new AB and the
Table 4. Frequency of isolates with AmpC and ESBL b-lactamases genes per sampling site.
b-lactamase group AWWTP N (%) EWWTP N (%) CWWN (%) HWWN (%) URWN (%) DRWN (%) Total N (%)
ESBL
TEM 3(30%) 1(9.1%) 1(16.7%) 5(27.8%) 1(25%) 2(40%) 13(24.0%)
OXA 7(70%) 4(36.4%) 5(27.8%) 2(50%) 1(20%) 18(33.3%)
CTX-M-1 1(10%) 1(9.1%) 2(3.7%)
CTX-M-9 1(10%) 1(1.9%)
AmpC
CIT 1(10%) 1(1.9%)
DHA 1(5.6%) 1(1.9%)
EBC 6(60%) 5(45.5%) 2(33.3%) 7(38.9%) 1(20%) 21(39.0%)
FOX 1(30%) 1(1.9%)
For sampling sites codes, cf. legend of Fig. 1; N (%), absolute and (relative) frequency of isolates carrying the gene.
public awareness of this serious problem, are not taken
seriously, mankind risks of back to the pre-AB era, where
the mortality rate was high due to numerous and common
bacterial infections that we have considered controlled.
The consequences will be also extended to the environ-
ment, with long-term negative impacts, including micro-
biota imbalances in environmental ecosystems, surface
and ground waters and soils. These environmental and
public health risks bring high challenges to this issue.
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